Aytu BioPharma, Inc. AYTU

2.28 (0.03) (1.30%) as of 25 Sep
Market cap
$25.1M
P/E
0.0×
Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
33.70 0.94 2.05 2.32 1.28 0.21 0.05 0.24 0.21 0.46
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.19
P/Operating CF
(33.21) (0.76) (4.31) (8.27) (13.37) (2.86) 0.57 (20.03) 4.88 6.01
P/B ratio
27.14 0.26 2.11 0.68 0.61 0.46 0.14 0.57 0.72 0.75
Price to Tangible BV
0.00 1.67 0.00 3.55 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
33.43 (1.00) 1.20 1.10 0.90 0.20 (0.01) 0.17 0.07 0.30
EV/EBITDA
0.00 0.21 0.00 0.00 0.00 0.00 0.17 1.90 0.00 0.00
EV/Operating CF
(7.79) 0.23 (0.64) (1.07) (2.26) (0.66) 0.25 (7.86) (2.35) 5.25
EV/FCF
(7.72) 0.22 (0.61) (0.76) (1.47) (0.45) 0.07 (0.97) (3.04) 5.32
Quick Ratio
0.39 2.27 2.43 1.88 0.71 0.64 0.75 0.70 0.98 0.90
Current Ratio
0.84 2.79 2.87 2.62 0.96 0.93 1.03 0.99 1.26 1.13
Net Debt/EBITDA
0.06 0.42 0.80 2.27 0.68 0.05 0.86 (0.85) 3.90 2.17
Debt/Assets
0.00% 0.00% 0.00% 9.46% 9.33% 13.22% 11.99% 12.81% 17.57% 16.22%
Debt/Equity
0.00 0.00 0.00 0.15 0.18 0.41 0.42 0.55 1.15 0.48
Asset Turnover
0.16 0.20 0.26 0.29 0.31 0.48 0.78 0.51 0.55 0.50
Operating CF/Net income
0.61 1.56 0.51 2.08 0.45 0.27 0.30 0.09 0.14 (0.23)
Capex/Depreciation
(0.02) (0.18) (0.21) (0.94) (0.11) 0.00 0.00 (0.04) 0.08 (0.01)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(319.60%) (116.94%) (264.55%) (26.68%) (50.12%) (119.62%) (40.76%) (47.24%) (58.10%) (52.55%)
ROA
(114.43%) (56.51%) (97.28%) (14.49%) (27.83%) (53.95%) (12.44%) (12.45%) (11.20%) (12.44%)
ROIC
(402.85%) (195.07%) 0.00% (21.59%) (32.72%) (159.24%) (32.58%) (4.35%) (49.77%) (19.99%)
Return on Tangible Assets
(34,416.36%) (161.86%) (264.34%) (29.03%) (6,227.46%) 7,310.42% (439.57%) (4,450.56%) (81.47%) (190.36%)
Average Days of Receivables
59.82 57.72 86.80 74.41 156.70 81.98 98.34 131.74 171.31 144.42
Research and Development Expense of Revenue
41.84% 4.58% 8.05% 6.23% 8.57% 13.10% 3.81% 4.25% 2.00% 0.00%
Selling, General and Administrative Expense of Revenue
546.55% 484.48% 262.82% 112.41% 85.03% 72.29% 65.25% 64.49% 57.67% 74.07%
Intangible Assets out of Total Assets
0.75 0.54 0.55 0.50 0.57 0.51 0.43 0.44 0.34 0.39
Share Based Compensation of Revenue
93.50% 16.31% 14.12% 3.90% 5.45% 6.90% 5.63% 3.64% 0.87% 1.20%
Graham Net Nets
(0.07) 0.53 (0.81) 0.27 (0.27) (1.65) (4.87) (1.80) (1.90) (0.30)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(418.31%) (295.13%) (233.33%) (20.88%) (70.50%) (552.17%) (309.28%) (100.35%) (87.16%) (53.30%)
Free Cash Flow Yield
(12.84%) (479.99%) (96.10%) (62.44%) (47.68%) (211.30%) (358.72%) (71.33%) (10.93%) 12.21%
Revenue per Share
1,400.70 1,109.12 187.70 122.27 78.38 65.76 32.16 11.77 10.57 4.67
Operating CF per Share
(6,012.91) (4,830.39) (354.65) (125.55) (31.01) (19.61) (1.54) (0.25) (0.31) 0.27
Capex per Share
(48.52) (143.85) (14.35) (25.88) (2.80) 0.00 0.00 (0.06) 0.07 0.00
Free Cash Flow per Share
(6,061.43) (4,974.24) (369.01) (151.43) (33.80) (19.61) (1.54) (0.31) (0.24) 0.26
Cash per Share
381.52 2,155.30 289.59 213.86 59.59 13.17 6.88 3.61 4.93 2.14
Shareholders Equity per Share
1,739.04 4,068.03 181.74 420.42 164.28 30.14 11.78 5.00 3.02 2.86
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1,739.04 4,068.03 181.74 420.42 164.28 30.14 11.78 5.00 3.02 2.86
Free Cash Flow
(13.94) (16.41) (14.39) (34.22) (28.30) (28.82) (5.13) (1.72) (1.50) 3.25
Working Capital
(0.58) 6.08 10.06 46.66 (4.20) (4.51) 2.06 (0.34) 16.12 7.10
Capital Expenditures
(0.11) (0.47) (0.56) (5.85) (2.34) — — (0.33) 0.44 (0.03)
Net Current Asset Value
(7.97) 1.83 (12.20) 17.14 (22.87) (33.39) (26.03) (28.49) (26.03) (7.97)
EV/EBIT
0.00 0.19 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00
Capex to Sales
0.03 0.13 0.08 0.21 0.04 0.00 0.00 0.01 (0.01) 0.00
Net Profit Margin
(698.67%) (278.35%) (370.63%) (49.29%) (88.81%) (112.53%) (15.88%) (24.31%) (20.43%) (24.76%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
7.26 11.85 13.39 24.12 4.28 28.26 5.16 10.57 10.31 10.50
Cash ROIC
(296.82%) (78.68%) (76.35%) (18.14%) (14.65%) (38.91%) (8.82%) (3.31%) (3.44%) 3.68%
Accounts Receivable Turnover
9.33 6.61 6.31 7.49 3.88 3.88 4.24 2.48 2.43 2.13
Accounts Payable Turnover
0.62 0.94 1.04 1.20 2.36 2.94 3.33 1.36 1.97 1.90
Inventory Turnover
1.54 1.55 1.58 1.45 2.77 3.27 3.57 1.34 1.74 2.27
Average Days of Payables
571.78 377.32 353.65 513.05 192.91 90.35 120.67 233.41 188.28 198.47
Days of Inventory on Hand
337.91 238.35 238.71 440.72 163.70 89.21 107.40 274.75 203.08 120.66
Average Receivables
0.35 0.55 1.16 3.69 16.90 24.94 25.32 26.23 27.34 26.97
Average Payables
2.27 2.17 2.13 6.89 15.45 15.12 12.23 11.90 10.46 10.94
Average Inventory
0.92 1.33 1.39 5.72 13.17 13.59 11.42 12.07 11.79 9.15
Average Assets
19.67 18.03 27.89 94.01 209.48 201.65 137.04 127.28 121.14 114.59
Average Common Equity
7.04 8.71 10.26 51.05 116.29 90.94 41.83 33.54 23.34 27.12

Fold the line items

Columns are period end dates · fundamentals updated 24 Sep 2026